Items where Author is "Bibi, S"
Up a level |
Bibi, S, Imran, A, Saud, S, Maheshwari, MK, Shankar Chowdhry, B and Ejaz, W (2023) Low-Cost 3D Holographic Display With Gesture Control. In: 2023 Global Conference on Wireless and Optical Technologies (GCWOT) . pp. 1-5. (2023 Global Conference on Wireless and Optical Technologies (GCWOT), 24th Jan - 27th Jan 2023, Malaga, Spain).
Feng, S, Phillips, DJ, White, T, Sayal, H, Aley, PK, Bibi, S, Dold, C, Fuskova, M, Gilbert, SC, Hirsch, I, Humphries, HE, Jepson, B, Kelly, EJ, Plested, E, Shoemaker, K, Thomas, KM, Vekemans, J, Villafana, TL, Lambe, T, Pollard, AJ , Voysey, M, Oxford COVID Vaccine Trial Group, , Tahmasebi, F and Smith, A (2021) Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection. Nature Medicine, 27 (11). pp. 2032-2040. ISSN 1078-8956
Flaxman, A, Marchevsky, NG, Jenkin, D, Aboagye, J, Aley, PK, Angus, B, Belij-Rammerstorfer, S, Bibi, S, Bittaye, M, Cappuccini, F, Cicconi, P, Clutterbuck, EA, Davies, S, Dejnirattisai, W, Dold, C, Ewer, KJ, Folegatti, PM, Fowler, J, Hill, AVS, Kerridge, S , Minassian, AM, Mongkolsapaya, J, Mujadidi, YF, Plested, E, Ramasamy, MN, Robinson, H, Sanders, H, Sheehan, E, Smith, H, Snape, MD, Song, R, Woods, D, Screaton, G, Gilbert, SC, Voysey, M, Pollard, AJ, Lambe, T, Oxford COVID Vaccine Trial group, and Tahmasebi, F (2021) Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002). Lancet, 398 (10304). pp. 981-990. ISSN 0140-6736
Voysey, M, Costa Clemens, SA, Madhi, SA, Weckx, LY, Folegatti, PM, Aley, PK, Angus, B, Baillie, VL, Barnabas, SL, Bhorat, QE, Bibi, S, Briner, C, Cicconi, P, Clutterbuck, EA, Collins, AM, Cutland, CL, Darton, TC, Dheda, K, Dold, C, Duncan, CJA , Emary, KRW, Ewer, KJ, Flaxman, A, Fairlie, L, Faust, SN, Feng, S, Ferreira, DM, Finn, A, Galiza, E, Goodman, AL, Green, CM, Green, CA, Greenland, M, Hill, C, Hill, HC, Hirsch, I, Izu, A, Jenkin, D, Joe, CCD, Kerridge, S, Koen, A, Kwatra, G, Lazarus, R, Libri, V, Lillie, PJ, Marchevsky, NG, Marshall, RP, Mendes, AVA, Milan, EP, Minassian, AM, McGregor, A, Mujadidi, YF, Nana, A, Padayachee, SD, Phillips, DJ, Pittella, A, Plested, E, Pollock, KM, Ramasamy, MN, Ritchie, AJ, Robinson, H, Schwarzbold, AV, Smith, A, Song, R, Snape, MD, Sprinz, E, Sutherland, RK, Thomson, EC, Török, ME, Toshner, M, Turner, DPJ, Vekemans, J, Villafana, TL, White, T, Williams, CJ, Douglas, AD, Hill, AVS, Lambe, T, Gilbert, SC, Pollard, AJ, Aban, M, Abeyskera, KWM, Aboagye, J, Adam, M, Adams, K, Adamson, JP, Adewatan, G, Adlou, S, Ahmed, K, Akhalwaya, Y, Akhalwaya, S, Alcock, A, Ali, A, Allen, ER, Allen, L, Alvernaz, FB, Amorim, FS, Andrade, CS, Andritsou, F, Anslow, R and Tahmasebi, F (2021) Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. The Lancet, 397 (10277). pp. 881-891. ISSN 0140-6736